Basic Information
Endosense SA is a medical device company dedicated to improving the efficacy, safety, and reproducibility of catheter ablation treatments for arrhythmias. Endosense SA's TactiCath® received CE certification in May 2009. It is the first and only force-sensing ablation catheter that provides doctors with real-time, objective measurements of contact force during catheter ablation procedures. TactiCath® has undergone extensive preclinical and clinical testing, and its results have provided a solid evidence base for the feasibility, safety, and value of contact force sensing during catheter ablation.
Endosense SA
Switzerland
51~100 people
January 01, 2003
info@endosense.com
